Just reported
From Sensus Healthcare's results release of November 12, 2026. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Actual
$6M
-13% y/y
+162% q/q
Guided
—
No guide given
Actual
-$1.6M
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The themes Sensus Healthcare is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
Built from Sensus Healthcare, Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
$3.39+2.3%Nov 11 close
The latest quarter (ended September 30, 2026) is from Sensus Healthcare’s earnings press release of November 12, 2026. It will be replaced by the official quarterly report (10-Q) once Sensus Healthcare files it.
Grade F-
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 39 quarters of Sensus Healthcare, Inc.’s grade history. The other 37 go back to May 2017.